Trials No Longer Recruiting
- SUB-TYPE OF MDS: MDS patients who are platelet transfusion dependent
- SEVERITY OF MDS: intermediate 1 & 2 or high risk
- NAME OF DRUG: Eltrombopag, Promacta™/Revolade™
Home » MDS Latest News » Trials No Longer Recruiting
Clinical trials are expected to recruit patients for a finite period of time. Each trial has an expected recruitment target, i.e. a specific number of patients needed to participate in the trial in order for the results of the trial to be meaningful and answer all of the proposed questions. Once this target is achieved, the trial is closed to recruitment and the data obtained from the trial is analysed and interpreted. It can take several months for this analysis to be completed. The final results are often published in international journals and/or presented at a scientific meeting.
Please visit the following page for Currently Open MDS Clinical Trials.
If you'd like more information about what is a clinical trial and how it is conducted, please go to this section